William J. Peters - Feb 8, 2022 Form 4 Insider Report for Amphastar Pharmaceuticals, Inc. (AMPH)

Role
CFO, EVP & Treasurer
Signature
/s/ William J. Peters
Stock symbol
AMPH
Transactions as of
Feb 8, 2022
Transactions value $
-$120,000
Form type
4
Date filed
2/9/2022, 08:06 PM
Previous filing
Jan 11, 2022
Next filing
Mar 1, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMPH Common Stock Options Exercise $150K +10K +9.43% $14.95 116K Feb 8, 2022 Direct
transaction AMPH Common Stock Sale -$270K -10K -8.62% $26.95 106K Feb 8, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMPH Employee Stock Option (right to buy) Options Exercise $0 -10K -17.22% $0.00 48.1K Feb 8, 2022 Common Stock 10K $14.95 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 7, 2021.
F2 Shares subject to the option are fully vested and immediately exercisable.